Sign In
Buy SOPH
$5.67
-0.0900 (-1.56%)
At Close: Jul 31, 2026
What Makes SOPHiA GENETICS (SOPH) a New Buy Stock
01:01pm, Friday, 09'th Aug 2024
SOPHiA GENETICS (SOPH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
SOPHiA GENETICS SA (SOPH) Reports Q2 Loss, Lags Revenue Estimates
08:56am, Tuesday, 06'th Aug 2024
SOPHiA GENETICS SA (SOPH) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to loss of $0.33 per share a year ago.
SOPHiA GENETICS Reports Second Quarter 2024 Results
06:45am, Tuesday, 06'th Aug 2024
Strength in U.S. Growth Offset by Challenges in BioPharma and EMEA; Strong Cost Management B uffers Loss BOSTON and ROLLE, Switzerland , Aug. 6, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a
SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM™
10:30am, Monday, 29'th Jul 2024
The hospital will use the SOPHiA DDM™ Platform to enhance its testing and research of blood cancers BOSTON and ROLLE, Switzerland , July 29, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cl
SOPHIA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix
11:59am, Wednesday, 24'th Jul 2024
OncoHelix is the first laboratory in Canada to adopt MSK-ACCESS® powered with SOPHiA DDM™ BOSTON and ROLLE, Switzerland , July 24, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-n
SOPHiA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix
10:00am, Wednesday, 24'th Jul 2024
OncoHelix is the first laboratory in Canada to adopt MSK-ACCESS® powered with SOPHiA DDM™ BOSTON and ROLLE, Switzerland , July 24, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-nati
SOPHiA GENETICS to Announce Financial Results for Second Quarter 2024 on August 6, 2024
06:45am, Tuesday, 23'rd Jul 2024
BOSTON and ROLLE, Switzerland , July 23, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it will release its
India-Based Dhiti Omics is Now Live on SOPHiA DDM™
02:30am, Thursday, 04'th Jul 2024
The diagnostics company has implemented the SOPHiA DDM™ Platform to enhance its solid tumor testing BOSTON and ROLLE, Switzerland , July 4, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a
SOPHiA GENETICS Publishes Results of 2024 Annual General Meeting
09:47am, Monday, 24'th Jun 2024
BOSTON and ROLLE, Switzerland, June 24, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a healthcare technology company and a leader in data-driven medicine, is pleased to announce that it
SOPHiA GENETICS Launches New Residual Acute Myeloid (RAM) Application
02:00am, Monday, 24'th Jun 2024
Novel application supports measurable residual disease (MRD) testing to help monitor cancer and stay ahead of relapse BOSTON and ROLLE, Switzerland , June 24, 2024 /PRNewswire/ -- SOPHiA GENETICS (Na
SOPHiA GENETICS Announces Kepler Uniklinikum is Live on SOPHiA DDM™ Platform
06:00am, Thursday, 13'th Jun 2024
The Hospital will use SOPHiA DDM™ to enhance its testing and research of blood cancers BOSTON and ROLLE, Switzerland , June 13, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native he
SOPHiA GENETICS Launches Global Consortium, SOPHiA UNITY, to Accelerate Cancer Research, Drug Development, and Data-Driven Patient Care
12:19pm, Thursday, 30'th May 2024
New collective intelligence network to enable the most advanced research in oncology in support of precision medicine BOSTON and ROLLE, Switzerland , May 30, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasd
SOPHiA GENETICS to Launch New Whole Genome Sequencing Capabilities
10:00am, Wednesday, 29'th May 2024
In collaboration with Microsoft and NVIDIA, SOPHiA GENETICS is developing a comprehensive whole genome analytical solution BOSTON and ROLLE, Switzerland , May 29, 2024 /PRNewswire/ -- SOPHiA GENETICS
SOPHiA GENETICS Announces Instituto Mário Penna as New Customer
10:02am, Monday, 20'th May 2024
The hospital will enhance its testing and research of blood cancers with the SOPHiA DDM™ Platform BOSTON and ROLLE, Switzerland , May 20, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a clou
Klinikum Klagenfurt am Wörthersee is Live with SOPHiA GENETICS
06:02am, Thursday, 16'th May 2024
The SOPHiA DDM™ Platform will help broaden the hospital's cancer testing and diagnostic capabilities BOSTON and ROLLE, Switzerland , May 16, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cl
